Safety of IL-1 blockade in pregnancy

Researchers from Universite de Montreal (Canada) and Manchester University (UK) have published a systematic review of studies describing IL-1 blockade in pregnancy. The review combines pregnancy exposure and outcome data following maternal anakinra and canakinumab use. More information can be found here.